Cachexia, Lung Neoplasms
Conditions
Keywords
Lipogenesis, Lipolysis, Phospholipids, Body Composition, Nutritional Status, Lipid Metabolism
Brief summary
The causes of failing nutrition status in advanced cancer are not well known. The way fat is moved, stored, burned or changed into other compounds may be affected and will be followed in patients using a tracer and other blood tests. The investigators hypothesize that fat loss and wasting results from low essential fatty acid availability in the body. Changes may occur in the liver that limits distribution and availability of fat to the body as an energy source or for other essential functions.
Detailed description
Weight loss in cancer is the result of breakdown of fat (lipid) and muscle protein reserves. This research will explore how people with cancer use fat in their body through the use of tracers and measures in the blood. A stable isotope of hydrogen called 'deuterium' is used to trace the production of different fats by the liver. Other methods will determine how much and what types of fat are transported around the body. Body composition will be determined by CT scan and related to fat measures.
Interventions
OTHERBlood draws
Up to 4 blood draws will be required, in the amount of about 10 mL each
BIOLOGICALOral administration of stable isotope (deuterium)
1 mg deuterium-labeled water/kg body water (loading dose), and 0.5 mg/kg body water diluted in 1 L of normal water (maintenance dose) to be consumed over the following 16 hours
PROCEDUREMetabolic rate testing
Metabolic rate testing is a painless, non-invasive test that takes about 1h. A metabolic cart is used, which detects the amount of oxygen and carbon dioxide the body uses. Patients will lie down on a bed for 30 minutes with lights dimmed and soft music to help them relax. After 30 minutes, a canopy will be placed over the patient's head and shoulders for 30 minutes for the analysis of breath samples. This test will be performed only once for this study.
Sponsors
Cross Cancer Institute
AHS Cancer Control Alberta
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Low plasma phospholipids OR low plasma ratio of triglycerides to free fatty acids * Recent weight loss * Advanced stage lung cancer (Stage 3 or 4)
Exclusion criteria
* Having symptoms that may affect measures of fat metabolism (nausea, vomiting, problems swallowing, etc.) * Taking n-3 fatty acid supplements such as fish oil
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of hepatic de novo lipogenesis | 9 months |
Secondary
| Measure | Time frame |
|---|---|
| Measures of fat transport and availability | 9 months |
| Resting metabolic rate & fat oxidation | 9 months |
Countries
Canada
Outcome results
None listed